Who
David M. Berman
Head of R&D
Company insider
Files Form 4 as: Head of R&D, Immunocore Holdings.
In numbers
- Trades disclosed
- 60
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $18.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Feb 2024
- Last trade
- 18 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $193K5,965 at $32.35 | filing |
| 18 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $193K5,965 at $32.35 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | —11,824 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,824 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,824 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | —11,824 at $0.00 | filing |
| 5 Dec 2025filed 8 Dec 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —572 at $0.00 | filing |
| 5 Dec 2025filed 8 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | $9,987572 at $17.46 | filing |
| 5 Dec 2025filed 8 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $23K572 at $40.14 | filing |
| 4 Dec 2025filed 8 Dec 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —31,341 at $0.00 | filing |
| 4 Dec 2025filed 8 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | $547K31,341 at $17.46 | filing |
| 4 Dec 2025filed 8 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $1.3M31,341 at $40.26 | filing |
| 28 Nov 2025filed 1 Dec 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,521 at $0.00 | filing |
| 28 Nov 2025filed 1 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | $96K5,521 at $17.46 | filing |
| 28 Nov 2025filed 1 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $221K5,521 at $40.09 | filing |
| 26 Nov 2025filed 1 Dec 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —69,404 at $0.00 | filing |
| 26 Nov 2025filed 1 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | $1.2M69,404 at $17.46 | filing |
| 26 Nov 2025filed 1 Dec 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $2.8M69,404 at $40.12 | filing |
| 25 Nov 2025filed 26 Nov 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,020 at $0.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | $315K18,020 at $17.46 | filing |
News
Immunocore (NASDAQ:IMCR) Shares Up 8% – Here's WhyIMCR · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name David M. Berman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.